IAS Stock Recent News
IAS LATEST HEADLINES
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming March 31, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON INTEGRAL AD SCIENCE HOLDING CORP. (IAS), CLICK HERE.
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=139512&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS" or the "Company") (NASDAQ:IAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=139368&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired IAS securities between March 2, 2023 and February 27, 2024, both dates inclusive (the "Class Period").
NEW YORK , March 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integral Ad Science Holding Corp. ("Integral Ad Science" or the "Company") (NASDAQ: IAS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integral Ad Science investors who were adversely affected by alleged securities fraud between March 2, 2023 and February 27, 2024.
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=139335&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY AND NEW ORLEANS / ACCESS Newswire / March 27, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 31, 2025 to file lead plaintiff applications in a securities class action lawsuit against Integral Ad Science Holding Corp. (the "Company") (NasdaqGS:IAS), if they purchased the Company's shares between March 2, 2023 and February 27, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=139280&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=139272&wire=1 or contact Joseph E. Levi, Esq.